What is the management for a 15-week pregnant woman with a history of in vitro fertilization (IVF) and hyperthyroidism on propylthiouracil (PTU), presenting with persistent vomiting and hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Persistent Vomiting with Hypotension in a 15-Week Pregnant Woman

This patient requires immediate hospitalization for intravenous fluid resuscitation, correction of electrolyte abnormalities, thiamine supplementation, and antiemetic therapy, while simultaneously evaluating for preeclampsia and other pregnancy-specific liver diseases. 1

Immediate Stabilization

Fluid Resuscitation and Monitoring

  • Admit to hospital immediately for intravenous hydration given the hypotension (systolic BP 80 mmHg) and persistent vomiting 1
  • Administer IV fluids to correct dehydration and restore blood pressure 1
  • Correct electrolyte abnormalities, which commonly include hyponatremia, hypokalaemia, and metabolic hypochloraemic alkalosis 2
  • Administer thiamine (vitamin B1) supplementation urgently to prevent Wernicke's encephalopathy, a serious complication of hyperemesis gravidarum 1, 2

Antiemetic Therapy

  • Initiate antiemetic therapy with ondansetron, which has favorable pregnancy safety 1
  • Alternative acceptable antiemetics include metoclopramide and promethazine 1
  • Oral prednisolone has no proven benefit; intravenous corticosteroids have conflicting data but can be considered for severe refractory disease 1

Diagnostic Evaluation

Rule Out Preeclampsia and Hypertensive Disorders

Critical pitfall: While this patient presents with hypotension, you must still evaluate for preeclampsia, as IVF pregnancy is a risk factor for hypertensive disorders of pregnancy 3. The hypotension may be due to severe dehydration masking underlying hypertension.

  • Once stabilized with fluids, reassess blood pressure to determine if hypertension emerges 1, 3
  • Check urine protein/creatinine ratio (abnormal if ≥30 mg/mmol or 0.3 mg/mg) 1
  • Obtain laboratory tests including: hemoglobin, platelet count, liver function tests (AST, ALT), renal function tests, and uric acid 1

Assess for Hyperemesis Gravidarum

  • This clinical presentation is consistent with hyperemesis gravidarum, characterized by prolonged severe vomiting, dehydration, and weight loss ≥5% of prepregnancy body weight 1
  • Check for ketonuria and elevated urine specific gravity 2
  • Liver enzyme abnormalities occur in ~50% of hyperemesis cases but rarely exceed 1,000 U/L, with ALT typically greater than AST 1
  • Important: Biochemical abnormalities typically resolve with hydration and resolution of vomiting; persistent liver chemistry abnormalities despite symptom resolution should prompt investigation for another etiology 1

Thyroid Function Assessment

  • Check free T4 and TSH levels, as hyperemesis can cause biochemical thyrotoxicosis with raised free thyroxine and/or suppressed TSH levels 2
  • This is distinct from her underlying hyperthyroidism on PTU and represents gestational transient thyrotoxicosis, which rarely requires treatment 4
  • Ensure PTU dosing remains appropriate to maintain free T4 in the high-normal range 4, 5

Thyroid Management Considerations

Continue PTU at 15 Weeks Gestation

  • At 15 weeks gestation, this patient should remain on PTU rather than switching to methimazole, as the switch is typically planned after week 13-14 but should be deferred during acute illness 3
  • PTU is preferred through the first trimester due to methimazole's association with rare fetal abnormalities 3, 6
  • Once the acute vomiting episode resolves and the patient is stable, consider switching to methimazole to minimize maternal hepatotoxicity risk in the second and third trimesters 3, 4
  • Monitor for PTU side effects including agranulocytosis, hepatitis, vasculitis, and thrombocytopenia 5

Fetal Monitoring

  • Confirm fetal well-being with ultrasound assessment 1
  • Monitor for fetal thyroid dysfunction, as PTU crosses the placenta and can cause fetal/neonatal hypothyroidism with or without goitre in 9.5% of cases 7
  • Fetal thyroid size monitoring by ultrasound is important for appropriate prevention and treatment 7

Common Pitfalls to Avoid

  • Do not assume normal blood pressure excludes preeclampsia risk in an IVF pregnancy with severe vomiting—reassess after fluid resuscitation 3
  • Do not delay thiamine supplementation, as Wernicke's encephalopathy, central pontine myelinolysis, and death can occur with inadequate treatment 2
  • Do not use intravenous hydralazine for blood pressure management if hypertension emerges, as it is associated with more perinatal adverse effects than other drugs 1
  • Do not discontinue PTU abruptly during acute illness, as untreated maternal hyperthyroidism increases risks of severe preeclampsia, preterm delivery, heart failure, miscarriage, and low birth weight 4

Expected Course

  • Hyperemesis gravidarum is not usually associated with major adverse maternal or fetal outcomes, though low birth weight and premature delivery have been associated 1
  • Biochemical abnormalities typically resolve with hydration and resolution of vomiting 1
  • Most patients improve spontaneously with intravenous fluids, antiemetics, and supportive care without long-term sequelae 2
  • Neonatal thyroid function typically normalizes during the first month of life without treatment in most cases of PTU exposure 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hypertension in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Suppressed TSH with Raised T4 and T3 in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hyperthyroidism During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.